1. 2017
  2. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients

    Marot, A., Belaid, A., Orlent, H., Sersté, T., Michielsen, P., Colle, I., Laleman, W., de Galocsy, C., Reynaert, H., D'Heygere, F., Moreno, C., Doerig, C., Henrion, J. & Deltenre, P., Dec 2017, In : Clinics and Research in Hepatology and Gastroenterology. 41, 6, p. 656-663 8 p.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Cessation of Nucleos(t)ide Analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients

    Van Hees, S., Bourgeois, S., Van Vlierberghe, H., Serste, T., Francque, S., Michielsen, P. P., Dirk, S., Reynaert, H., Henrion, J., Dastis, S. N., Delwaide, J., Lasser, L., Decaestecker, J., Orlent, H., Janssens, F., Robaeys, G., Colle, I., Starkel, P., Moreno, C., Nevens, F. & 1 othersVanwolleghem, T., Oct 2017, In : Hepatology. 66, SI, p. 500A-500A

    Research output: Contribution to journalMeeting abstract (Journal)Research

  4. Disease Control on Lanreotide Autogel® 120 mg in a Patient with Metastatic Gastrinoma: A Case Report

    Aerts, M. & Reynaert, H., 6 Sep 2017, In : Case Rep Gastroenterol. 11, 3, p. 616-623 8 p.

    Research output: Contribution to journalArticleResearchpeer-review

  5. ECV-associated miRNA levels as non-invasive biomarkers for early-stage HBV/HCV-induced fibrosis

    Lambrecht, J., Poortmans, P. J., Verhulst, S., Reynaert, H., Mannaerts, I. & van Grunsven, L. A., 22 Apr 2017.

    Research output: Unpublished contribution to conferencePosterResearch

  6. Liver cirrhosis and thyroid function: Friend or foe?

    Vincken, S., Reynaert, H., Schiettecatte, J., Kaufman, L. & Velkeniers-Hoebanckx, B., Apr 2017, In : Acta Clinica Belgica. 72, 2, p. 85-90 6 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. ECV-associated miRNA levels as novel markers for early-stage liver fibrosis by chronic HBV/HCV-infection

    Lambrecht, J., Poortmans, P. J., Verhulst, S., Reynaert, H., Mannaerts, I. & van Grunsven, L. A., 28 Mar 2017.

    Research output: Unpublished contribution to conferencePosterResearch

  8. Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis

    Lambrecht, J., Poortmans, P. J., Verhulst, S., Reynaert, H., Mannaerts, I. & van Grunsven, L. A., 9 Feb 2017, In : Frontiers in Pharmacology. 8, FEB, p. 1-13 13 p., 56.

    Research output: Contribution to journalArticleResearchpeer-review

  9. Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium

    Degré, D., Sersté, T., Lasser, L., Delwaide, J., Starkel, P., Laleman, W., Langlet, P., Reynaert, H., Bourgeois, S., Vanwolleghem, T., Negrin Dastis, S., Gustot, T., Geerts, A., Van Steenkiste, C., de Galocsy, C., Lepida, A., Orlent, H. & Moreno, C., 26 Jan 2017, In : PLoS ONE. 12, 1, 11 p., e0170933.

    Research output: Contribution to journalArticleResearchpeer-review

  10. ECV-associated miRNA levels as novel markers for early-stage liver fibrosis by chronic HBV/HCV-infection.

    Lambrecht, J., Poortmans, P. J., Reynaert, H., Mannaerts, I. & van Grunsven, L. A., 12 Jan 2017, (Unpublished).

    Research output: Unpublished contribution to conferencePosterResearch

  11. ECV-associated miRNA levels as non-invasive biomarkers for early-stage HBV/HCV-induced liver fibrosis

    Lambrecht, J., Poortmans, P. J., Reynaert, H., Mannaerts, I. & van Grunsven, L. A., 2017, In : Journal of Hepatology. 66, 1, p. S662-S662

    Research output: Contribution to journalMeeting abstract (Journal)Research

Previous 1 2 3 4 5 6 7 8 ...25 Next

ID: 33804